- Home
- LGND vs EVT Comparison
LGND vs EVT Comparison
Compare LGND & EVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- EVT
- Stock Information
- Founded
- LGND 1987
- EVT 2003
- Country
- LGND United States
- EVT United States
- Employees
- LGND N/A
- EVT N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- EVT Finance Companies
- Sector
- LGND Health Care
- EVT Finance
- Exchange
- LGND Nasdaq
- EVT Nasdaq
- Market Cap
- LGND 2.0B
- EVT 1.6B
- IPO Year
- LGND 1992
- EVT N/A
- Fundamental
- Price
- LGND $102.19
- EVT $23.21
- Analyst Decision
- LGND Strong Buy
- EVT
- Analyst Count
- LGND 8
- EVT 0
- Target Price
- LGND $144.71
- EVT N/A
- AVG Volume (30 Days)
- LGND 118.3K
- EVT 140.9K
- Earning Date
- LGND 05-08-2025
- EVT 01-01-0001
- Dividend Yield
- LGND N/A
- EVT 8.50%
- EPS Growth
- LGND N/A
- EVT N/A
- EPS
- LGND N/A
- EVT 6.63
- Revenue
- LGND $181,488,000.00
- EVT $69,404,302.00
- Revenue This Year
- LGND $17.68
- EVT N/A
- Revenue Next Year
- LGND $18.69
- EVT N/A
- P/E Ratio
- LGND N/A
- EVT $3.51
- Revenue Growth
- LGND 53.40
- EVT N/A
- 52 Week Low
- LGND $77.43
- EVT $19.20
- 52 Week High
- LGND $129.90
- EVT $25.83
- Technical
- Relative Strength Index (RSI)
- LGND 44.63
- EVT 55.70
- Support Level
- LGND $98.90
- EVT $22.89
- Resistance Level
- LGND $103.17
- EVT $23.29
- Average True Range (ATR)
- LGND 3.05
- EVT 0.35
- MACD
- LGND -0.27
- EVT -0.03
- Stochastic Oscillator
- LGND 31.94
- EVT 54.12
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About EVT Eaton Vance Tax Advantaged Dividend Income Fund of Beneficial Interest
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND is a diversified, closed-end management investment company. Its objective is to provide a high level of after-tax total return consisting mainly of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of electric utilities, energy equipment and services, food products, health care providers and services, internet software and services, and other areas.